Quarterly report pursuant to Section 13 or 15(d)

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)

v3.3.0.814
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2014
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]          
Research and Development Expense $ 300,783 $ 144,231 $ 931,360 $ 366,275  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares) 7,405,190   7,405,190   5,990,190
Registration Payment Arrangement, Accrual Carrying Value $ 0   $ 0   $ 55,620
Employee Stock Option [Member]          
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares) 7,405,190   7,405,190   5,990,190
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number (in Shares) 5,382,134   5,382,134   3,799,559